Your browser doesn't support javascript.
loading
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
Stefanovic, Stefan; Wallwiener, Markus; Karic, Uros; Domschke, Christoph; Katic, Luka; Taran, Florin-Andrei; Pesic, Aleksandra; Hartkopf, Andreas; Hadji, Peyman; Teufel, Martin; Schuetz, Florian; Sohn, Christof; Fasching, Peter; Schneeweiss, Andreas; Brucker, Sara.
Afiliação
  • Stefanovic S; Department of Gynecology and Obstetrics, Heidelberg University Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
  • Wallwiener M; Department of Gynecology and Obstetrics, Heidelberg University Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany. markus.wallwiener@med.uni-heidelberg.de.
  • Karic U; IMDI Science Center, International Medical Diplomacy Institute, Vodovodska 27a, Belgrade, 11000, Serbia.
  • Domschke C; Department of Gynecology and Obstetrics, Heidelberg University Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
  • Katic L; IMDI Science Center, International Medical Diplomacy Institute, Vodovodska 27a, Belgrade, 11000, Serbia.
  • Taran FA; Department of Women's Health, University Hospital Tuebingen, Calwerstr. 7, 72076, Tübingen, Germany.
  • Pesic A; IMDI Science Center, International Medical Diplomacy Institute, Vodovodska 27a, Belgrade, 11000, Serbia.
  • Hartkopf A; Department of Women's Health, University Hospital Tuebingen, Calwerstr. 7, 72076, Tübingen, Germany.
  • Hadji P; Department of Bone Oncology, Gynecological Endocrinology and Reproductive Medicine, Philipps-University of Marburg-Krankenhaus Nordwest, Steinbacher Hohl 2-26, 60488, Frankfurt am Main, Germany.
  • Teufel M; Department of Psychosomatic Medicine and Psychotherapy/Psycho-Oncology, Tuebingen University Hospital, Osianderstr. 5, 72076, Tuebingen, Germany.
  • Schuetz F; Department of Gynecology and Obstetrics, Heidelberg University Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
  • Sohn C; Department of Gynecology and Obstetrics, Heidelberg University Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
  • Fasching P; Department of Gynecology and Obstetrics, Erlangen University Hospital, Universitätsstraße 21-23, 91054, Erlangen, Germany.
  • Schneeweiss A; Department of Gynecology and Obstetrics, Heidelberg University Hospital, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.
  • Brucker S; National Center for Tumor Diseases (NCT) Heidelberg, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany.
Support Care Cancer ; 25(2): 549-558, 2017 02.
Article em En | MEDLINE | ID: mdl-27747478
PURPOSE: The capture of adequate treatment outcomes and quality of life (QOL) of advanced breast cancer patients in clinical routine represents a great challenge. Patient-reported outcomes (PROs) are data elements directly reported by patients about experiences with care, including symptoms, functional status, or quality of life. There is growing interest in the medical community for the evaluation and implementation of PROs of adverse events (PRO-AEs). Recent interest in PROs in health care has evolved in the context of patient centeredness. Our primary objective was to identify trials that had implemented PRO-AEs in the breast cancer treatment setting, thereby demonstrating its feasibility. We aimed to identify published studies that used patient reports to assess AEs during and after breast cancer treatment, to identify clinician underreported and modifiable AEs that are important to patients, and to analyze the feasibility and usefulness of PRO instrument implementation in everyday oncological practice with special attention given to electronic-based PRO instruments. METHODS: We conducted a systematic search of PubMed for studies that used PRO instruments to assess AEs of breast cancer treatment in the metastatic and adjuvant settings. Two authors independently reviewed the search results and decided which studies fully met the predefined inclusion criteria. RESULTS: The search yielded 606 publications. The two reviewers found that 9 studies met the inclusion criteria. Three AEs were identified as important to patients but inadequately reported by health care providers, namely hot flushes, vaginal dryness, and weight gain. CONCLUSIONS: PROs and PRO-AEs are the consequence of contemporary concepts of patient-centered medicine and the growing feasibility, utility, and implications of collecting data using modern technology. Furthermore, the willingness of patients to utilize innovative applications for their own health has been increasing in parallel to the enhanced impact of the World Wide Web. Especially, the coverage of the metastatic situation promises numerous findings on the structure and quality of health care, enabling implementation of individually tailored interventions. Remote electronic self-reporting (i.e., home reporting) is feasible and is associated with high compliance levels.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Medidas de Resultados Relatados pelo Paciente Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias da Mama / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Medidas de Resultados Relatados pelo Paciente Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha